Found: 88
Select item for more details and to access through your institution.
The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II).
- Published in:
- Orphanet Journal of Rare Diseases, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13023-024-03373-w
- By:
- Publication type:
- Article
The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.863667
- By:
- Publication type:
- Article
Gender-sensitive association of CFTR gene mutations and 5T allele emerging from a large survey on infertility.
- Published in:
- Molecular Human Reproduction, 2005, v. 11, n. 8, p. 607, doi. 10.1093/molehr/gah214
- By:
- Publication type:
- Article
The role of enzyme replacement therapy in severe Hunter syndrome-an expert panel consensus.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Mucopolysaccharidosis VI: the Italian experience.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.
- Published in:
- 2008
- By:
- Publication type:
- journal article
RETRACTED: Wiesinger et al. An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis. Pharmaceutics 2023, 15 , 1565.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 5, p. 1565, doi. 10.3390/pharmaceutics15051565
- By:
- Publication type:
- Article
Open issues in Mucopolysaccharidosis type I-Hurler.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Ten years of the Hunter Outcome Survey (HOS): insights, achievements, and lessons learned from a global patient registry.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical efficacy of Enzyme Replacement Therapy in paediatric Hunter patients, an independent study of 3.5 years.
- Published in:
- Orphanet Journal of Rare Diseases, 2014, v. 9, n. 1, p. 2, doi. 10.1186/s13023-014-0129-1
- By:
- Publication type:
- Article
Clinical efficacy of enzyme replacement therapy in paediatric Hunter patients, an independent study of 3.5 years.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Treatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedure.
- Published in:
- Orphanet Journal of Rare Diseases, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1750-1172-8-155
- By:
- Publication type:
- Article
Treatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedure.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Acid Sphingomyelinase Deficiency: A Clinical and Immunological Perspective.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 23, p. 12870, doi. 10.3390/ijms222312870
- By:
- Publication type:
- Article
Accurate Molecular Diagnosis of Gaucher Disease Using Clinical Exome Sequencing as a First-Tier Test.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5538, doi. 10.3390/ijms22115538
- By:
- Publication type:
- Article
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 8, p. 2014, doi. 10.3390/ijms20082014
- By:
- Publication type:
- Article
Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II MouseModel.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 5, p. 1072, doi. 10.3390/ijms18051072
- By:
- Publication type:
- Article
Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The ethical framework for performing research with rare inherited neurometabolic disease patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Human amniotic fluid stem cells protect rat lungs exposed to moderate hyperoxia.
- Published in:
- Pediatric Pulmonology, 2013, v. 48, n. 11, p. 1070, doi. 10.1002/ppul.22791
- By:
- Publication type:
- Article
The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression.
- Published in:
- Metabolic Brain Disease, 2017, v. 32, n. 5, p. 1529, doi. 10.1007/s11011-017-0044-y
- By:
- Publication type:
- Article
Research activity and capability in the European reference network MetabERN.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Non-convulsive status epilepticus of frontal origin in mucopolysaccharidosis type II successfully treated with ethosuximide.
- Published in:
- Developmental Medicine & Child Neurology, 2012, v. 54, n. 10, p. 961, doi. 10.1111/j.1469-8749.2012.04228.x
- By:
- Publication type:
- Article
Gene therapy: A new approach for the treatment of genetic disorders.
- Published in:
- Clinical Pharmacology & Therapeutics, 1990, v. 47, n. 1, p. 1, doi. 10.1038/clpt.1990.1
- By:
- Publication type:
- Article
Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges.
- Published in:
- International Journal of Environmental Research & Public Health, 2023, v. 20, n. 6, p. 4732, doi. 10.3390/ijerph20064732
- By:
- Publication type:
- Article
Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD).
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 8, p. 1437, doi. 10.1007/s10198-023-01667-7
- By:
- Publication type:
- Article
Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on "Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11 , 5158"
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 12, p. 4017, doi. 10.3390/jcm12124017
- By:
- Publication type:
- Article
Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS).
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 5158, doi. 10.3390/jcm11175158
- By:
- Publication type:
- Article
Plasma Neurofilament Light (NfL) in Patients Affected by Niemann–Pick Type C Disease (NPCD).
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 20, p. 4796, doi. 10.3390/jcm10204796
- By:
- Publication type:
- Article
Mucopolysaccharidoses Differential Diagnosis by Mass Spectrometry-Based Analysis of Urine Free Glycosaminoglycans—A Diagnostic Prediction Model.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 3, p. 532, doi. 10.3390/biom13030532
- By:
- Publication type:
- Article
Segregation analysis in a family at risk for the Maroteaux–Lamy syndrome conclusively reveals c.1151G>A (p.S384N) as to be a polymorphism.
- Published in:
- European Journal of Human Genetics, 2009, v. 17, n. 9, p. 1160, doi. 10.1038/ejhg.2009.19
- By:
- Publication type:
- Article
Continued improvement in disease manifestations of acid sphingomyelinase deficiency for adults with up to 2 years of olipudase alfa treatment: open-label extension of the ASCEND trial.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02983-0
- By:
- Publication type:
- Article
Together4RD position statement on collaboration between European reference networks and industry.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02853-9
- By:
- Publication type:
- Article
Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC Task Force.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02650-4
- By:
- Publication type:
- Article
Immunologic privilege in the central nervous system and the blood-brain barrier.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2013, v. 33, n. 1, p. 13, doi. 10.1038/jcbfm.2012.153
- By:
- Publication type:
- Article
Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment.
- Published in:
- BMC Medical Genomics, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1755-8794-6-37
- By:
- Publication type:
- Article
Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Rare disease education in Europe and beyond: time to act.
- Published in:
- Orphanet Journal of Rare Diseases, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13023-022-02527-y
- By:
- Publication type:
- Article
Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results.
- Published in:
- Orphanet Journal of Rare Diseases, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13023-022-02587-0
- By:
- Publication type:
- Article
Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
One year of COVID-19: infection rates and symptoms in patients with inherited metabolic diseases followed by MetabERN.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Social and medical needs of rare metabolic patients: results from a MetabERN survey.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Molecular markers for the follow-up of enzyme-replacement therapy in mucopolysaccharidosis type VI disease.
- Published in:
- Biotechnology & Applied Biochemistry, 2008, v. 049, n. 3, p. 219
- By:
- Publication type:
- Article
Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
U-IMD: the first Unified European registry for inherited metabolic diseases.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Parkinson's disease in Gaucher disease patients: what's changing in the counseling and management of patients and their relatives?
- Published in:
- 2020
- By:
- Publication type:
- journal article